Destination: Cure

Oral Report Could something as simple as oral care affect viral reservoirs? by Jeannie Wraight Research performed at Case Western found increased levels of HIV in the...

Risk & Reward Activist David Evans weighs in on next steps in cure advocacy & research by Jeannie Wraight In the late 1980s and throughout the ’90s,...

Gaining Momentum HIV vaccine candidates seek to make good on their early promise by Jeannie Wraight and David Miller Over the past several years, momentum for the...

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...

Fast Look Cure research highlights from CROI 2018 by Jeannie Wraight The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...

For only the second time in the history of the AIDS pandemic, a patient with HIV in London seems to have been freed of...

Mosaic Design APPROACH, a preventive vaccine study, seeks to address more than one clade by Jeannie Wraight Over the past thirty-plus years, strategies such as Treatment as...

LifeGuide Cure—or Bust Amid advances and setbacks in care, we must still aim for the end of HIV by Jeannie Wraight   I recently read a rather angry reader...

Step by Step At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation by Jeannie Wraight This year marked the 24th annual Conference on Retroviruses...

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...